{"@id":"https://bioecon.ru/technology/immunoglobulin-receptor-domain-modulators/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/immunoglobulin-receptor-domain-modulators/","json":"https://en.bioecon.ru/api/v1/technology/immunoglobulin-receptor-domain-modulators/index.json"},"id":"immunoglobulin-receptor-domain-modulators","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/pitura-seeds/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/lavajet/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/pakka/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/samsung-biologics/","https://bioecon.ru/companies/wuxi-biologics/"]},"maturity":7,"name":"Immunoglobulin Receptor-Domain Modulators","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Structural domain mapping"},{"n":2,"title":"Domain-specific selection"},{"n":3,"title":"Allosteric signaling modulation"},{"n":4,"title":"Translational efficacy testing"}],"summary":"Engineered biologic modalities specifically targeting the variable (IgV) and constant (IgC) structural domains of immunoglobulin superfamily receptors, precisely tuning co-stimulatory and co-inhibitory immune checkpoints in oncology and autoimmunity.","url":"/technology/immunoglobulin-receptor-domain-modulators/","verified":"2026-11-22"}